"La Clinique Saint-Luc Bouge est un hôpital de 302 lits agréés en médecine interne et chirurgie, auxquels s'ajoutent 24 lits d'hospitalisation de jour. Elle offre de nombreuses consultations accessibles sur son site et dans ses Centres Médicaux ( Andenne, Gembloux, Namur, Perwez). Depuis de nombreuses années, elle s'affirme comme une institution de pointe dans le domaine de la santé privilégiant la qualité des soins et l'accueil des patients. En évolution constante, elle ne cesse de se moderniser, en perpétuelle recherche de technologies médicales innovantes. Parkings, cafétéria - boutique, crèche... diverses facilités permettent aux patients, visiteurs et travailleurs d'évoluer dans un environnement pratique et paisible."

During the past decade, Clinique Saint Luc conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinique Saint Luc" #1 sponsor was "Astes" with 12 trials, followed by "Cliniques universitaires Saint-Luc- Université Catholique de Louvain" with 4 trials sponsored, "Labo'Life" with 2 trials sponsored, "University Hospital, Antwerp" with 2 trials sponsored and "Abbott Medical Devices" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinique Saint Luc" #1 collaborator was "Grand Hôpital de Charleroi" with 2 trials as a collaborator, "Anticancerfund" with 1 trials as a collaborator, "Edwards Lifesciences" with 1 trials as a collaborator, "Ferring Pharmaceuticals" with 1 trials as a collaborator and "Iqvia Pty Ltd" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Clinique Saint Luc" are "Metastatic Colorectal Cancer" (3 trials), "Sleep Apnea, Obstructive" (3 trials), "Anesthesia" (2 trials), "Adjuvant Therapy" (1 trials) and "Advanced or Metastatic Renal Cell Carcinoma" (1 trials). Many other conditions were trialed in "Clinique Saint Luc" in a lesser frequency.

Most popular intervention types in "Clinique Saint Luc" are "Drug" (10 trials), "Other" (9 trials), "Diagnostic Test" (4 trials), "Procedure" (4 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Irinotecan" (2 trials), "Oxaliplatin" (2 trials), "2LHERP®" (1 trials) and "2LVERU® or 2LVERU® JUNIOR" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinique Saint Luc" are 29 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Clinique Saint Luc". undefined are not yet recruiting, 9 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Clinique Saint Luc, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Clinique Saint Luc, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 4 trials that are defined as “Not Applicable".